| |
| |
|
| Insider
Information: |
Shafer Bradford J |
| Relationship: |
EVP, Gen. Counsel, Sec... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
720,844 |
|
|
Indirect Shares
|
8,250 |
|
|
| Direct
Value |
$9,834,001 |
|
|
|
Indirect Value
|
$133,568 |
|
|
| Total
Shares |
729,094 |
|
|
| Total
Value |
$9,967,569 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Innoviva Inc |
INVA |
Sr VP, Gen. Counsel, S... |
2014-08-20 |
443,013 |
2014-08-12 |
8,250 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
EVP, Gen. Counsel, Sec... |
2021-08-20 |
277,831 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
103 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2006-05-03 |
4 |
OE |
$3.10 |
$189,989 |
D/D |
40,761 |
271,735 |
|
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2011-11-28 |
4 |
OE |
$8.53 |
$257,649 |
D/D |
30,205 |
370,673 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-03-03 |
4 |
OE |
$9.69 |
$937,488 |
D/D |
96,773 |
392,537 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2010-02-20 |
4 |
D |
$10.22 |
$11,886 |
D/D |
(1,163) |
250,664 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Sr VP, Gen. Counsel, Secretary |
• – – |
2015-08-20 |
4 |
D |
$12.98 |
$12,123 |
D/D |
(934) |
156,019 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2010-05-20 |
4 |
D |
$13.02 |
$20,103 |
D/D |
(1,544) |
249,120 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Sr VP, Gen. Counsel, Secretary |
• – – |
2015-06-02 |
4 |
D |
$13.83 |
$101,789 |
D/D |
(7,360) |
156,953 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2010-08-20 |
4 |
D |
$14.00 |
$21,602 |
D/D |
(1,543) |
247,577 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2009-11-20 |
4 |
D |
$14.04 |
$13,633 |
D/D |
(971) |
226,827 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2021-08-20 |
4 |
D |
$14.05 |
$60,513 |
D/D |
(4,307) |
277,831 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2009-05-20 |
4 |
D |
$14.06 |
$13,301 |
D/D |
(946) |
228,744 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Sr VP, Gen. Counsel, Secretary |
• – – |
2015-05-20 |
4 |
D |
$14.24 |
$9,584 |
D/D |
(673) |
164,313 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-08-11 |
4 |
OE |
$14.53 |
$489,182 |
D/D |
33,667 |
474,430 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2009-02-20 |
4 |
D |
$14.87 |
$8,595 |
D/D |
(578) |
192,690 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Sr VP, Gen. Counsel, Secretary |
• – – |
2016-02-20 |
4 |
D |
$15.65 |
$296,098 |
D/D |
(18,920) |
136,165 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2008-07-30 |
4 |
S |
$15.97 |
$553,689 |
D/D |
(34,676) |
193,268 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2004-10-05 |
4 |
B |
$16.00 |
$44,000 |
D/D |
2,750 |
230,974 |
2.74 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2004-10-05 |
4 |
B |
$16.00 |
$132,000 |
I/I |
8,250 |
2,750 |
1.99 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Sr VP, Gen. Counsel, Secretary |
• – – |
2015-11-20 |
4 |
D |
$17.17 |
$16,037 |
D/D |
(934) |
155,085 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2020-11-20 |
4 |
D |
$17.21 |
$82,728 |
D/D |
(4,807) |
251,916 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2011-08-20 |
4 |
D |
$17.50 |
$37,100 |
D/D |
(2,120) |
342,589 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2019-11-20 |
4 |
D |
$17.60 |
$62,779 |
D/D |
(3,567) |
175,334 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2021-05-20 |
4 |
D |
$17.80 |
$76,718 |
D/D |
(4,310) |
282,138 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2020-08-20 |
4 |
D |
$18.22 |
$87,529 |
D/D |
(4,804) |
256,723 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2012-02-20 |
4 |
D |
$18.54 |
$178,373 |
D/D |
(9,621) |
346,052 |
0 |
- |
|
103 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
